Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective

Area of Science:

• Virology
• Clinical Diagnostics
• Transplant Medicine

Background:

• Cytomegalovirus (CMV) significantly contributes to transplant patient morbidity and mortality.
• Quantitative molecular assays are standard for monitoring CMV.
• Effective management of CMV disease relies on informed clinical decision-making regarding testing.

Purpose of the Study:

• To highlight critical aspects of quantitative CMV DNA testing for clinicians.
• To emphasize factors influencing clinical decision-making in CMV disease management.

Main Methods:

• Review of key parameters in quantitative CMV DNA assays.
• Consideration of biological properties of CMV relevant to testing.

Main Results:

• Specimen type (whole blood vs. plasma) impacts results.
• Assay characteristics (limit of detection, quantification, linear range, reproducibility) vary significantly.
• Inter-assay variability in viral load measurements is substantial.
• Inherent biological properties of CMV (in-host variability, half-life) affect interpretation.

Conclusions:

• Clinicians must be aware of assay-specific details and biological variability for accurate CMV DNA test interpretation.
• Informed interpretation of quantitative CMV DNA testing is essential for optimal patient management in transplant settings.